INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤═════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                   │   Score │
╞════════════════════════════════════════════════════╪═════════════════════════════════════════════════╪═════════╡
│ Pregnant, lactating, or intending to become        │ Pregnant, lactating, or intending to become     │     100 │
│ pregnant during the study                          │ pregnant during the study                       │         │
├────────────────────────────────────────────────────┼─────────────────────────────────────────────────┼─────────┤
│ Response assessment of complete response (CR),     │ Response assessment of complete response (CR),  │      98 │
│ partial response (PR), or long-term stable disease │ partial response (PR), long stable disease (SD) │         │
│ (SD) for \>6 months with a cancer immunotherapy    │ for >3 months with a cancer immunotherapy       │         │
│ treatment for metastatic cancer or hematologic     │ treatment for metastatic cancer or hematologic  │         │
│ malignancies either through a marketed CPI or      │ malignancies either through a marketed CPI or   │         │
│ through participation in a Roche/Genentech CPI     │ through participation in a Roche/Genentech CPI  │         │
│ clinical trial                                     │ clinical trial                                  │         │
╘════════════════════════════════════════════════════╧═════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years                 │ Pregnant, lactating, or intending to become        │      31 │
│                                                   │ pregnant during the study                          │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Availability of tissue sample                     │ Availability of tumor biopsy material extracted    │      43 │
│                                                   │ and preserved by the investigating site            │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Participants receiving CPI treatment as part of a │ Participants taking CPI combination therapies with │      50 │
│ non-Roche/Genentech clinical trial                │ chemotherapy are not permitted                     │         │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Availability of tissue sample                     │ Availability of tumor biopsy material extracted    │      43 │
│                                                   │ and preserved by the investigating site            │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Participants receiving CPI treatment as part of a │ Participants taking CPI combination therapies with │      50 │
│ non-Roche/Genentech clinical trial                │ chemotherapy are not permitted                     │         │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 77
Average Levenshtein Ratio of individual lines: 59.285714285714285
OverAll Ratio: 68.14285714285714
